Business
CHM CDH17 ADVANCES TO DOSE LEVEL 2
CHM CDH17 ADVANCES TO DOSE LEVEL 2

About this update from Chimeric Therapeutics Limited
Chimeric Therapeutics Ltd has released a press release. View Attachment
View stock analysis, news, and events for Chimeric Therapeutics Limited